Syndax Pharmaceuticals Inc (SNDX) - Insider Holders & Insider Ownership

List of insiders holdings for Syndax Pharmaceuticals Inc:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Domain Partners VI L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
VITULLO NICOLE
10% Owner		2016-03-08 11:47:211,743,854
0		1,743,854Form 4
2BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF INC
LAMPERT MARK N
10% Owner		2023-02-14 11:53:101,451,197
0		1,451,197Form 13G
3Domain Partners VIII L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
VITULLO NICOLE
Halak Brian K
10% Owner		2021-01-20 19:57:091,162,554
0		1,162,554Form 13G
4ROYSTON IVOR
Director		2017-03-22 13:37:240
625,545		625,545Form 4
5Metzger Michael A
Chief Executive Officer		2026-02-10 09:00:18491,690
0		491,690Form 4
6Botwood Nicholas A.J.
Head of R&D, CMO		2026-02-06 16:50:19239,865
0		239,865Form 4
7Podlesak Dennis
Director		2026-02-06 16:14:08239,763
0		239,763Form 4
8Sabus Steve M
Chief Commercial Officer		2022-12-05 16:41:39220,000
0		220,000Form 4
9Goldan Keith A.
Chief Financial Officer		2026-02-10 08:59:55140,429
0		140,429Form 4
10Shaw Allan
Chief Financial Officer		2016-03-02 18:06:46137,600
0		137,600Form 3
11Katkin Keith
Director		2026-02-06 16:13:08124,000
0		124,000Form 4
12Jarrett Jennifer
Director		2026-02-06 17:16:26114,000
0		114,000Form 4
13Legault Pierre
Director		2026-02-06 16:06:23114,000
0		114,000Form 4
14Madigan Catherine
Chief Medical Officer		2023-02-03 17:01:12110,000
0		110,000Form 4
15Huber Martin H. Jr.
Director		2026-02-06 16:55:20103,000
0		103,000Form 4
16Karydas Daphne
Chief Financial Officer		2021-02-05 16:22:1995,000
0		95,000Form 4
17Meury William
Director		2025-02-07 16:38:3390,000
0		90,000Form 4
18Gallagher Neil
President, Head of R&D		2025-02-12 17:13:2485,095
0		85,095Form 4
19Shea Richard P
Chief Financial Officer		2020-02-14 16:37:1753,227
0		53,227Form 4
20Rizo Aleksandra
Director		2026-02-06 16:13:3649,000
0		49,000Form 4
21Meyers Michael L.
SVP, Chief Medical Officer		2022-02-03 17:31:5342,344
0		42,344Form 4
22Morrison Briggs
Director		2024-02-09 16:04:0834,836
0		34,836Form 4
23Egros Fabrice
Director		2022-02-03 17:29:4432,000
0		32,000Form 4
24Nolte Alexander
Chief Accounting Officer		2023-02-03 16:58:2417,000
0		17,000Form 4
25Chen Henry
Director		2018-05-25 09:00:2514,000
0		14,000Form 4
26EVNIN LUKE
Director
10% Owner		2018-05-25 09:00:1114,000
0		14,000Form 4
27DP VI Associates L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
VITULLO NICOLE
Director
10% Owner		2016-03-08 11:52:2613,925
0		13,925Form 4
28DOMAIN ASSOCIATES
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
VITULLO NICOLE
Halak Brian K
Kamdar Kim P.
Shah Nimesh
10% Owner		2016-03-02 18:37:2713,564
0		13,564Form 3
29Kamdar Kim P.
Director
10% Owner		2016-11-02 16:44:508,000
0		8,000Form 4
30DP VIII Associates L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
VITULLO NICOLE
Halak Brian K
10% Owner		2016-03-08 11:41:425,641
0		5,641Form 4
31Sledge George W. Jr.
Director		2017-05-19 11:27:015,000
0		5,000Form 4
32Ordentlich Peter
Chief Scientific Officer		2023-02-17 18:09:580
0		0Form 4
33MPM BioVentures IV QP LP
Scopa James Paul
Foley Todd
GADICKE ANSBERT
KAILIAN VAUGHN M
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV GmbH & Co. Beteiligungs KG
MPM BioVentures IV GP LLC
MPM BioVentures IV LLC
MPM BioVentures IV Strategic Fund L.P.
10% Owner		2021-02-12 16:06:570
0		0Form 13G